JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144493

QX-314 chloride (N-Ethyllidocaine chloride) (mM/ml), Na+ channel blocker

Be the first to review this product! Submit a review

|

(4 Publications)

MW 298.8 Da, Purity >99%. A membrane impermeable quaternary lidocaine derivative. Blocks voltage-sensitive Na+ channels. Soluble in 1 ml water to give specified mM/ml concentration.
1 Images
Chemical Structure - QX-314 chloride (N-Ethyllidocaine chloride) (mM/ml), Na+ channel blocker (AB144493)
  • Chemical Structure

Lab

Chemical Structure - QX-314 chloride (N-Ethyllidocaine chloride) (mM/ml), Na+ channel blocker (AB144493)

2D chemical structure image of ab144493, QX-314 chloride (N-Ethyllidocaine chloride) (mM/ml), Na+ channel blocker

Key facts

CAS number

5369-03-9

Purity

>99%

Form

Solid

form

Molecular weight

298.8 Da

Molecular formula

C<sub>1</sub><sub>6</sub>H<sub>2</sub><sub>7</sub>ClN<sub>2</sub>O

PubChem

21462

Nature

Synthetic

Biochemical name

QX 314 chloride

Biological description

A membrane impermeable quaternary lidocaine derivative. Blocks voltage-sensitive Na+ channels. Soluble in 1 ml water to give specified mM/ml concentration.

Canonical smiles

CC[N+](CC)(CC)CC(=O)NC1=C(C=CC=C1C)C.[Cl-]

InChi

InChI=1S/C16H26N2O.ClH/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5;/h9-11H,6-8,12H2,1-5H3;1H

InChiKey

LLPPOMUAOGMYQI-UHFFFAOYSA-N

IUPAC Name

[2-(2,6-dimethylanilino)-2-oxoethyl]-triethylazanium;chloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

The Journal of neuroscience : the official journal of the Society for Neuroscience 33:9259-72 PubMed23719795

2013

Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis.

Applications

Unspecified application

Species

Unspecified reactive species

Tamara Perez-Rosello,Charles T Anderson,Francisco J Schopfer,Yanjun Zhao,David Gilad,Sonia R Salvatore,Bruce A Freeman,Michal Hershfinkel,Elias Aizenman,Thanos Tzounopoulos

Journal of neurophysiology 106:2570-9 PubMed21832038

2011

Pre- and postsynaptic properties of glutamatergic transmission in the immature inhibitory MNTB-LSO pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel T Case,Deda C Gillespie

Neuron 71:180-94 PubMed21745647

2011

Multiple clusters of release sites formed by individual thalamic afferents onto cortical interneurons ensure reliable transmission.

Applications

Unspecified application

Species

Unspecified reactive species

Martha W Bagnall,Court Hull,Eric A Bushong,Mark H Ellisman,Massimo Scanziani

Neuropsychopharmacology : official publication of 36:1801-10 PubMed21525858

2011

Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.

Applications

Unspecified application

Species

Unspecified reactive species

Vanessa A Mitchell,Hyo-Jin Jeong,Geoffrey M Drew,Christopher W Vaughan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com